A low virulent strain of Candida albicans enhances brain anticryptococcal defenses: Characterization of the local immune reaction by RT-PCR and histochemical analysis

Journal of Neuroimmunology

Volumn 79, Issue 1, 1997, Pages 37-48

  Barluzzi, Roberta ^a   Mazzolla, Rosanna ^a   Brozzetti, Annalisa ^a   Puliti, Manuela ^a   Mariucci, Giuseppina ^b   Mosci, Paolo ^a   Bistoni, Francesco ^a   Blasi, Elisabetta ^c  

^a Microbiology Section   (Italy)

^b Dept Exp Med Biochem Sci U   (Italy)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Cryptococcosis; Cytokines; Glial cells; Inflammation

Indexed keywords

AMINOGUANIDINE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PENTOXIFYLLINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CONTROLLED STUDY; FUNGAL MENINGITIS; HISTOCHEMISTRY; IMMUNE RESPONSE; IMMUNOSTIMULATION; MENINGOENCEPHALITIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL; VIRULENCE;

ANIMALS; ANTIBODIES, FUNGAL; ANTIBODY FORMATION; BRAIN; CANDIDA ALBICANS; CRYPTOCOCCUS NEOFORMANS; CYTOKINES; DISEASE SUSCEPTIBILITY; GENE EXPRESSION; GUANIDINES; IMMUNITY; MICE; MICE, INBRED C57BL; NITRIC OXIDE SYNTHASE; PENTOXIFYLLINE; POLYMERASE CHAIN REACTION; SURVIVAL ANALYSIS; TRANSCRIPTION, GENETIC;

EID: 0030708556     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(97)00105-7     Document Type: Article

References (50)

1. Aguirre K., Havell E.A., Gibson G.W., Johnson L.L. Role of tumor necrosis factor and gamma interferon in acquired resistance to Cryptococcus neoformans in the central nervous system of mice. Infect. Immun. 63:1995;1725-1731.
2. Aguirre K.M., Sayles P.C., Gibson G.W., Johnson L.L. Resistance of Cryptococcus neoformans is associated with an inflammatory response to Toxoplasma gondii in the central nervous system of mice. Infect. Immun. 64:1996;77-82.
3. Bistoni F., Vecchiarelli A., Cenci E., Puccetti P., Marconi P., Cassone A. Evidence for macrophage mediated protection against lethal Candida albicans infection. Infect. Immun. 51:1986;668-674.
4. Blasi E., Mazzolla R., Barluzzi R., Mosci P., Bartoli A., Bistoni F. Intracerebral transfer of an in vitro established microglial cell line: Local induction of a protective state against lethal challenge with Candida albicans. J. Neuroimmunol. 32:1991;249-257.
5. Blasi E., Barluzzi R., Mazzolla R., Mosci P., Bistoni F. Experimental model of intracerebral infection with Cryptococcus neoformans. Roles of phagocytes and opsonization. Infect. Immun. 60:1992;3682-3688.
6. Blasi E., Barluzzi R., Mazzolla R., Bistoni F. Differential host susceptibility to intracerebral infections with Candida albicans and Cryptococcus neoformans. Infect. Immun. 61:1993;3476-3481.
7. Blasi E., Mazzolla R., Pitzurra L., Barluzzi R., Bistoni F. Protective effect of picolinic acid on mice intracerebrally infected with lethal doses of Candida albicans. Antimicrob. Agents Chemother. 37:1993;2422-2426.
8. Blasi E., Bartoli A., Barluzzi R., Mazzolla R., Bistoni F. Pattern of cytokine gene expression in brains of mice protected by picolinic acid against lethal intracerebral infection with Candida albicans. J. Neuroimmunol. 52:1994;205-213.
9. Blasi E., Mazzolla R., Barluzzi R., Mosci P., Bistoni F. Anticryptococcal resistance in the mouse brain: Beneficial effects of local administration of heat-inactivated yeast cells. Infect. Immun. 62:1994;3189-3196.
10. Blasi E., Barluzzi R., Mazzolla R., Pitzurra L., Puliti M., Saleppico S., Bistoni F. Biomolecular events involved in anticryptococcal resistance in the brain. Infect. Immun. 63:1995;1218-1222.
11. Blasi E., Barluzzi R., Mazzolla R., Tancini B., Saleppico S., Puliti M., Pitzurra L., Bistoni F. Role of nitric oxide and melanogenesis in the accomplishment of anticryptococcal activity by the BV-2 microglial cell-line. J. Neuroimmunol. 58:1995;111-116.
12. Buchanan K.L., Murphy J.W. Characterization of cellular infiltrates and cytokine production during the expression phase of the anti-cryptococcal delayed-type hypersensitivity response. Infect. Immun. 61:1992;2854-2865.
13. Chao C.C., Hu S., Molitor T.W., Shaskan E.G., Peterson P.K. Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J. Immunol. 149:1992;2736-2741.
14. Chao C.C., Hu S., Gekker G., Novick W.J. Jr., Remington J.S., Peterson P.K. Effects of cytokines on multiplication of Toxoplasma gondii in microglial cells. J. Immunol. 150:1993;3404-3410.
15. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
16. Chuck S.L., Sande M.A. Infection with Cryptococcus neoformans in the acquired immunodeficiency syndrome. New Engl. J. Med. 321:1989;794-799.
17. Collins H.L., Bancroft G.J. Cytokine enhancement of complement-dependent phagocytosis by macrophages: Synergy of tumor necrosis factor- and granulocyte-macrophage colony-stimulating factor for phagocytosis of Cryptococcus neoformans. Eur. J. Immunol. 22:1992;1447-1454.
18. Cross A.H., Misko T.P., Lin R.F., Hickey W.F., Trotter J.L., Tilton R.G. Aminoguanidina, an inhibitor of inducible nitric oxide synthase, ameliorates experimental immune encephalomyelitis in SJL mice. J. Clin. Invest. 93:1994;2684-2690.
19. Cunha A., Jefferson J.A., Jackson R.W., Vitkovic' L. Glial cell-specific mechanisms of TGF-β1 induction by IL-1 in cerebral cortex. J. Neuroimmunol. 42:1993;71-86.
20. Eng R.H.K., Bishburg E., Smith S.M. Cryptococcal infections in patients with acquired immune deficiency syndrome. Am. J. Med. 81:1986;19-23.
21. Fabry Z., Raine C.S., Hart M.N. Nervous tissue as an immune compartment: The dialect of the immune response in the CNS. Immunol. Today. 15:1994;218-224.
22. Fierz W., Endler B., Reske K., Wekerle H., Fontana A. Astrocytes as antigen-presenting cells. Induction of Ia antigen on astrocytes by T cells via immune interferon and its effect on antigen presentation. J. Immunol. 134:1985;3785-3790.
23. Frei K., Siepl C., Groscurth P., Bodmer S., Schwerdel C., Fontana A. Antigen presentation and tumor cytotoxicity by interferon-gamma-treated microglial cells. Eur. J. Immunol. 17:1987;1271-1278.
24. Frei K., Malpiero U.V., Leist T.P., Zinkernagel R.M., Schwab M.E., Fontana A. On the cellular source and function of interleukin 6 produced in the central nervous system in viral diseases. Eur. J. Immunol. 19:1989;689-694.
25. Gentri L.O., Remington J.S. Resistance against Cryptococcus conferred by intracellular bacteria and protozoa. J. Infect. Dis. 123:1971;22-31.
26. Giulian D. Ameboid microglia as effectors of inflammation in the central nervous system. J. Neurosci. Res. 18:1987;155-171.
27. Giulian D., Baker J., Shih L.N., Lachman L.B. Interleukin 1 of the central nervous system is produced by ameboid microglia. J. Exp. Med. 164:1986;594-604.
28. Griffiths M.J.D., Messent M., MacAllister R.J., Evans T.W. Aminoguanidine selectively inhibits inducible nitric oxide synthase. Br. J. Pharmacol. 110:1993;963-968.
29. Hidore M.R., Nabavi N., Sonleitner F., Murphy J.W. Murine natural killer cells are fungicidal to Cryptococcus neoformans. Infect. Immun. 59:1991;1747-1754.
30. + T cell-dependent acquired state of immunity that protects the brain against Cryptococcus neoformans. Infect. Immun. 59:1994;1747-1754.
31. Kossmann M.C.M., Kossmann T.K., Wahl S.M. Cytokines and neuropathology. Trends Pharmacol. Sci. 13:1992;286-291.
32. Kwon-Chung K.J., Rhodes J.C. Encapsulation and melanin formation as indicators of virulence in Cryptococcus neoformans. Infect. Immun. 51:1986;218-223.
33. Lee S.C., Dickson D.W., Brosnan C.F., Casadevall A. Human astrocytes inhibit Cryptococcus neoformans growth by a nitric oxide-mediated mechanism. J. Exp. Med. 180:1994;365-369.
34. Lee S.C., Kress Y., Dickson D.W., Casadevall A. Human microglia mediate anti-Cryptococcus neoformans activity in the presence of specific antibody. J. Neuroimmunol. 62:1995;43-52.
35. Mazzolla R., Barluzzi R., Romani L., Mosci P., Bistoni F. Anti-Candida resistance in the mouse brain and effect of intracerebral administration of interleukin-1. J. Gen. Microbiol. 137:1991;1799-1804.
36. Mazzolla R., Barluzzi R., Puliti M., Saleppico S., Bistoni F., Blasi E. Biomolecular events involved in the establishment of brain anticandidal resistance. J. Neuroimmunol. 64:1996;9-17.
37. Miller M.F., Mitchell T.G. Killing of Cryptococcus neoformans strains by human neutrophils and monocytes. Infect. Immun. 59:1991;24-28.
38. Misko T.P., Moore W.N., Kasten T.P., Nickols C.A., Corbett J.A., Tilton R.G., McDaniel M.L., Williamson J.R., Currie M.G. Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur. J. Pharmacol. 233:1993;119-122.
39. + (L3T4) lymphocytes in vivo impairs murine host defense to Cryptococcus neoformans. J. Immunol. 144:1990;1472-1477.
40. Mukherjee J., Pirofski L.A., Scharff M.D., Casadevall A. Antibody-mediated protection in mice with lethal intracerebral Cryptococcus neoformans infection. Proc. Natl. Acad. Sci. USA. 90:1993;3636-3640.
41. Murphy J.W. Influence of cryptococcal antigens on cell-mediated immunity. Rev. Infect. Dis. 10:1988;5432-5435.
42. Pietroski N.A., Pharm D., Stern J.J. Cryptococcal meningitis and other fungal infections of the central nervous system. Curr. Opin. Infect. Dis. 3:1990;608-613.
43. Polacheck I., Platt Y., Aronovitch J. Catecholamines and virulence of Cryptococcus neoformans. Infect. Immun. 58:1990;2919-2922.
44. Roseff S.A., Levitz S.M. Effect of endothelial cells on phagocyted-mediated anticryptococcal activity. Infect. Immun. 61:1993;3818-3824.
45. Suzumura A., Sawada M., Itoh Y., Marunouchi T. Interleukin-4 induces proliferation and activation of microglia but suppresses their induction of class II major histocompatibility complex antigen expression. J. Neuroimmunol. 53:1994;209-218.
46. van Furth A.M., Roord J.J., van Furth R. Roles of proinflammatory and anti-inflammatory cytokines in pathophysiology of bacterial meningitis and effect of adjunctive therapy. Infect. Immun. 64:1996;4883-4890.
47. Vecchiarelli A., Retini C., Pietrella D., Monari C., Tascini C., Beccari T., Kozel T.R. Downregulation by cryptococcal polysaccharide of tumor necrosis factor alfa and interleukin-1β secretion from human monocytes. Infect. Immun. 63:1995;2919-2923.
48. Watabe K., Osborne D., Kim S.U. Phagocytic activity of human adult astrocytes and oligodendrocytes in culture. J. Neuropathol. Exp. Neurol. 48:1989;499-506.
49. Yoshida A., Koide Y., Uchijeama M., Yoshida T.O. Dissection of strain difference in acquired protective immunity against Mycobacterium bovis Calmette-Guerin bacillus (BCG). J. Immunol. 155:1995;2057-2066.
50. Zielasek J.M., Tausch M., Toyka K.V., Hartung H.P. Production of nitrite by neonatal rat microglial cells/brain macrophages. Cell. Immunol. 141:1992;111-120.